Flu Vaccine Testimony: Chiron's View on Preparedness

Overview:

In early 2004, long before the news that Chiron Corp.'s Fluvirin would not be available for the 2004-2005 flu season, firm president Howard Pien testified before the U.S. House of Representatives about the company's role in meeting the nation's vaccine needs. Read what he had to say.